Orencia (abatacept) for injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  

December 2014

Summary View


  • In clinical trials of 2688 adult RA patients treated with intravenous Orencia, there were two cases (<0.1%) of anaphylaxis or anaphylactoid reactions…


February 2012

Summary View

Warnings and Precautions

  • to include information regarding serious infections.


Page Last Updated: 01/15/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English